The present application relates to novel, substituted dihydropyrazolonederivativesrepresented by(see formula I)processes for their preparation, their use for treatment and/or prophylaxis ofdiseases and their usefor the preparation of medicaments for treatment and/or prophylaxis ofdiseases, in particularcardiovascular and haematological diseases and kidney diseases, and forpromoting woundhealing.